‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’

Iqbal Singh

doi:10.7860/jcdr/2015/12526.6019

journal article Jan 01, 2015

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’

Iqbal Singh

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · JCDR Research and Publications

View at Publisher Save 10.7860/jcdr/2015/12526.6019

Topics

No keywords indexed for this article. Browse by subject →

Cited By

2

Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis

Zhinan Fan, Hongjin Shi · 2022

Frontiers in Pharmacology

Metrics

2

Citations

0

References

Details

Published: Jan 01, 2015

Authors

I

Iqbal Singh

Zydus Medical College and Hospital, Gujarat, India

Cite This Article

Iqbal Singh (2015). ‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2015/12526.6019

‘Tamsulosin and Darifenacin’ Versus ‘Tamsulosin Monotherapy’ for ‘BPH with Accompanying Overactive Bladder’

You May Also Like